Atorvastatin-Induced Necrotizing Myopathy and its Response to Combination Therapy

Cureus. 2021 Jan 28;13(1):e12957. doi: 10.7759/cureus.12957.

Abstract

Atorvastatin is the most commonly used statin medication to decrease cholesterol levels and prevent atherosclerosis. Myopathy is a reported side effect of atorvastatin which can happen even after more than six months after starting the medication. The side effect on the muscle tissue can range from simple reversible myalgia to respiratory muscle compromise. Here we present a 46-year-old male who presented with myopathy after taking atorvastatin for two years. Biopsy proved immune-mediated necrotizing myopathy which responded to a combination of Rituximab and intravenous immunoglobulin therapy.

Keywords: atorvastatin; myopathy.

Publication types

  • Case Reports